Thanks to Reviewers

Journal of Cardiovascular Pharmacology and Therapeutics · Published 2025-01-01 · DOI 10.1177/10742484251315246

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1177/10742484251315246

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• The Role of JAK/STAT Signaling Pathway and Its Downstream Influencing Factors in the Treatment of Atherosclerosis · Journal of Cardiovascular Pharmacology and Therapeutics · 2024 · Same journal
• LncRNA Sirt1-AS Protects Against Cardiac Hypertrophy by Modulating Sirt1 · Journal of Cardiovascular Pharmacology and Therapeutics · 2025 · Same journal
• The Prognostic Value of the Triglyceride Glucose Index in Patients With Acute Myocardial Infarction · Journal of Cardiovascular Pharmacology and Therapeutics · 2023 · Same journal
• Clinical Evaluation of QTc Interval Prolongation With the Dual Endothelin Receptor Antagonist Aprocitentan · Journal of Cardiovascular Pharmacology and Therapeutics · 2025 · Same journal
• Impact of Intravenous Nitrate Treatment on Antiplatelet Effects of Clopidogrel in Acute Coronary Syndrome Patients: A Pilot Study · Journal of Cardiovascular Pharmacology and Therapeutics · 2025 · Same journal
• Impact of SGLT2 Inhibitors on Left Ventricular Remodeling in Diabetic Patients with Acute Myocardial Infarction · Journal of Cardiovascular Pharmacology and Therapeutics · 2024 · Same journal
• The Clinical Implementation of CYP2C19 Genotyping in Patients with an Acute Coronary Syndrome: Insights From the FORCE-ACS Registry · Journal of Cardiovascular Pharmacology and Therapeutics · 2023 · Same journal
• Anticoagulation for Atrial Fibrillation in Acute Coronary Syndrome Survivors Reduces Major Cardiovascular Events and Mortality · Journal of Cardiovascular Pharmacology and Therapeutics · 2023 · Same journal
• Vericiguat reduces electrical and structural remodeling in a rabbit model of atrial fibrillation · Journal of Cardiovascular Pharmacology and Therapeutics · 2023 · Same journal
• Fondaparinux Sodium: Recent Advances in the Management of Thrombosis · Journal of Cardiovascular Pharmacology and Therapeutics · 2023 · Same journal